EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antisense oligonucleotide rescue of CGG expansion–dependent FMR1 mis-splicing in fragile X syndrome restores FMRP

Sneha Shah iD, Kevin J Sharp, Sithara Raju Ponny, Jonathan Lee, Jonathan K Watts iD, Elizabeth Berry-Kravis, Joel D Richter iD

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2302534120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Sneha Shah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605. Hauptthemen laut MEDLINE: Fragile X Syndrome. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, NIGMS NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant alternative splicing of mRNAs results in dysregulated gene expression in multiple neurological disorders. Here, we show that hundreds of mRNAs are incorrectly expressed and spliced in white blood cells and brain tissues of individuals with fragile X syndrome (FXS). Surprisingly, the FMR1 (Fragile X Messenger Ribonucleoprotein 1) gene is transcribed in >70% of the FXS tissues. In all FMR1 -expressing FXS tissues, FMR1 RNA itself is mis-spliced in a CGG expansion–dependent manner to generate the little-known FMR1 -217 RNA isoform, which is comprised of FMR1 exon 1 and a pseudo-exon in intron 1. FMR1 -217 is also expressed in FXS premutation carrier–derived skin fibroblasts and brain tissues. We show that in cells aberrantly expressing mis-spliced FMR1 , antisense oligonucleotide (ASO) treatment reduces FMR1 -217, rescues full-length FMR1 RNA, and restores FMRP (Fragile X Messenger RibonucleoProtein) to normal levels. Notably, FMR1 gene reactivation in transcriptionally silent FXS cells using 5-aza-2′-deoxycytidine (5-AzadC), which prevents DNA methylation, increases FMR1 -217 RNA levels but not FMRP. ASO treatment of cells prior to 5-AzadC application rescues full-length FMR1 expression and restores FMRP. These findings indicate that misregulated RNA-processing events in blood could serve as potent biomarkers for FXS and that in those individuals expressing FMR1-217 , ASO treatment may offer a therapeutic approach to mitigate the disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fragile X SyndromeHumansTrinucleotide Repeat ExpansionOligonucleotides, AntisenseDecitabineFragile X Messenger Ribonucleoprotein 1OligonucleotidesRNA

Stichwörter der Autor:innen

FMR1FMRPRNA splicingantisense oligonucleotides

Substanzen

Oligonucleotides, AntisenseDecitabineFragile X Messenger Ribonucleoprotein 1OligonucleotidesRNAFMR1 protein, human

Autor:innen und Institutionen

  • Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605.
  • Department of Pediatrics, Rush University Medical Center, Chicago, IL 60612.
  • RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01605.
  • Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605.
  • Li Weibo Rare Disease Institute, University of Massachusetts Chan Medical School, Worcester, MA 01605.
  • Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612.

ORCID-Profile: Sneha Shah, Jonathan K Watts, Joel D Richter

Förderung

  • NCATS NIH HHS
  • NIGMS NIH HHS
  • NINDS NIH HHS
  • FRAXA Research Foundation
  • Simons Foundation Autism Research Initiative
  • HHS | National Institutes of Health
  • HHS | NIH | National Center for Advancing Translational Sciences
  • University of Massachusetts Chan Medical School BRIDGE Fund

Zitieren

APA

Shah, S., Sharp, K. J., Raju Ponny, S., Lee, J., Watts, J. K., Berry-Kravis, E., & Richter, J. D. (2023). Antisense oligonucleotide rescue of CGG expansion–dependent FMR1 mis-splicing in fragile X syndrome restores FMRP. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2302534120

Vancouver

Shah S, Sharp KJ, Raju Ponny S, Lee J, Watts JK, Berry-Kravis E, et al. Antisense oligonucleotide rescue of CGG expansion–dependent FMR1 mis-splicing in fragile X syndrome restores FMRP. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2302534120

BibTeX
@article{Shah2023,
  author = {Shah, Sneha and Sharp, Kevin J and Raju Ponny, Sithara and Lee, Jonathan and Watts, Jonathan K and Berry-Kravis, Elizabeth and Richter, Joel D},
  title = {Antisense oligonucleotide rescue of CGG expansion–dependent FMR1 mis-splicing in fragile X syndrome restores FMRP},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2302534120}
}
Kostenlos starten →